感染管理用アパレル市場-世界の産業規模、シェア、動向、機会、予測、製品別、最終用途別、地域別、競合別セグメント、2020～2030年

感染管理用アパレルの世界市場は、2024年には173億1,000万米ドルとなり、2030年には222億9,000万米ドルに達し、CAGR 4.50%で成長すると予測されています。

COVID-19パンデミックは、個人用保護具（PPE）の需要を加速させる上で極めて重要な役割を果たし、ヘルスケアと非ヘルスケアセグメントでの感染管理用アパレルの普及につながりました。感染予防は依然として世界的に重要な関心事であるため、この勢いが今後の市場成長を維持すると予想されます。

感染管理用アパレルは、材料科学と繊維工学の進歩により、通気性、体液抵抗性、抗菌保護などの機能を備えた衣服が生み出され、特にリスクの高い臨床現場で不可欠なものとして、さらなる牽引力を増しています。しかし、市場は引き続き障害に直面しており、特に先進的防護衣の製造と調達に関連するコストが高いため、コストに敏感な地域では採用が制限される可能性があります。

主要市場促進要因

ヘルスケア産業の成長

主要市場課題

先端材料のコスト上昇

主要市場動向

eコマースとデジタル流通プラットフォームの成長

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界の感染管理用アパレル市場に与える影響

第5章 世界の感染管理用アパレル市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（隔離ガウン、化学療法ガウン、白衣、ジャケット）
  • 最終用途別（病院、外来・外科センター、クリニック、調査・診断ラボ、その他）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米の感染管理用アパレル市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の感染管理用アパレル市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の感染管理用アパレル市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の感染管理用アパレル市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの感染管理用アパレル市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 世界の感染管理用アパレル市場：SWOT分析

第15章 ポーターのファイブフォース分析

• 産業内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第16章 競合情勢

• 3M Company
• DuPont de Nemours, Inc.
• Cardinal Health, Inc.
• Owens & Minor, Inc.
• Medline Industries, Inc.
• Lindstrom Group
• Ansell Ltd
• Delta Plus Group
• Lakeland Industries Inc.
• Protective Industrial Products, Inc.

第17章 戦略的提言

第18章 調査会社について・免責事項

The Global Infection Control Apparel Market was valued at USD 17.31 billion in 2024 and is projected to reach USD 22.29 billion by 2030, growing at a CAGR of 4.50%. The COVID-19 pandemic played a pivotal role in accelerating the demand for personal protective equipment (PPE), leading to the widespread adoption of infection control apparel across healthcare and non-healthcare sectors. As infection prevention remains a key concern worldwide, this momentum is expected to sustain future market growth.

Infection control apparel is gaining further traction due to advancements in material science and textile engineering, which are yielding garments with features such as breathability, fluid resistance, and antimicrobial protection-particularly vital in high-risk clinical settings. However, the market continues to face obstacles, especially the high costs tied to manufacturing and procuring advanced protective garments, which can limit adoption in cost-sensitive regions.

Key Market Drivers

Growth in Healthcare Industry

The global healthcare industry's expansion is a primary force behind the rising demand for infection control apparel. With annual revenues exceeding USD 4 trillion, the industry comprises several major segments, including pharmaceuticals and biotechnology (USD 850 billion) and medical technology and diagnostics (USD 400 billion). As healthcare systems scale up across both developed and developing regions, the volume of clinical activities, surgical procedures, and patient admissions has also surged, leading to increased implementation of infection control measures.

The prevalence of healthcare-associated infections (HAIs) further underlines the critical role of protective apparel. On average, one in ten hospitalized patients contracts an HAI, with rates significantly higher in low- and middle-income countries. Vulnerable populations, such as ICU patients, face even greater risks. In Europe, the overall burden of the six most common HAIs surpasses that of 32 other major infectious diseases combined, reinforcing the necessity for effective infection prevention strategies, including the use of high-quality protective clothing.

Key Market Challenges

Rising Cost of Advanced Materials

The rising cost of high-performance materials used in manufacturing infection control apparel is a significant hurdle in market growth. Products like surgical gowns, gloves, masks, and coveralls now incorporate specialized materials with features such as antimicrobial properties, enhanced fluid resistance, and breathability. These sophisticated fabrics-including multi-layer synthetics and coated nonwovens-are notably more expensive than traditional materials.

With global safety standards becoming more rigorous, manufacturers must invest in materials that meet stringent performance and regulatory criteria. This increase in production cost elevates end-product pricing, posing financial challenges for healthcare systems-especially in regions where budget constraints impact purchasing decisions.

Key Market Trends

Growth of E-Commerce and Digital Distribution Platforms

The expansion of e-commerce and digital distribution platforms is emerging as a transformative trend in the global infection control apparel market. As demand for PPE and infection control garments grows across healthcare and industrial sectors, manufacturers and suppliers are increasingly utilizing digital channels to reach broader customer bases and streamline procurement.

Notably, initiatives such as Toray Industries' collaboration with the Guinean government underscore the growing role of digital and global outreach in supporting infectious disease prevention. Online portals now allow hospitals and healthcare professionals to place orders more efficiently, track inventory in real-time, and access regulatory documentation-offering significant advantages over traditional supply chains.

Key Market Players

• 3M Company
• DuPont de Nemours, Inc.
• Cardinal Health, Inc.
• Owens & Minor, Inc.
• Medline Industries, Inc.
• Lindstrom Group
• Ansell Ltd
• Delta Plus Group
• Lakeland Industries Inc.
• Protective Industrial Products, Inc.

Report Scope

In this report, the Global Infection Control Apparel Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Infection Control Apparel Market, By Product:

• Isolation Gowns
• Chemotherapy Gowns
• Lab Coats
• Jackets

Infection Control Apparel Market, By End Use:

• Hospitals
• Ambulatory & Surgical Centers
• Clinics
• Research & Diagnostic Labs
• Others

Infection Control Apparel Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Infection Control Apparel Market.

Available Customizations

Global Infection Control Apparel Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Infection Control Apparel Market

5. Global Infection Control Apparel Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Isolation Gowns, Chemotherapy Gowns, Lab Coats, Jackets)
  • 5.2.2. By End Use (Hospitals, Ambulatory & Surgical Centers, Clinics, Research & Diagnostic Labs, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Infection Control Apparel Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Infection Control Apparel Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End Use
  • 6.3.2. Mexico Infection Control Apparel Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End Use
  • 6.3.3. Canada Infection Control Apparel Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End Use

7. Europe Infection Control Apparel Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Infection Control Apparel Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End Use
  • 7.3.2. Germany Infection Control Apparel Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom Infection Control Apparel Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Infection Control Apparel Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Infection Control Apparel Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End Use

8. Asia Pacific Infection Control Apparel Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Infection Control Apparel Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End Use
  • 8.3.2. India Infection Control Apparel Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End Use
  • 8.3.3. South Korea Infection Control Apparel Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End Use
  • 8.3.4. Japan Infection Control Apparel Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia Infection Control Apparel Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End Use

9. South America Infection Control Apparel Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Infection Control Apparel Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina Infection Control Apparel Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia Infection Control Apparel Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End Use

10. Middle East and Africa Infection Control Apparel Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Infection Control Apparel Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia Infection Control Apparel Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End Use
  • 10.3.3. UAE Infection Control Apparel Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Infection Control Apparel Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. 3M Company
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. DuPont de Nemours, Inc.
• 16.3. Cardinal Health, Inc.
• 16.4. Owens & Minor, Inc.
• 16.5. Medline Industries, Inc.
• 16.6. Lindstrom Group
• 16.7. Ansell Ltd
• 16.8. Delta Plus Group
• 16.9. Lakeland Industries Inc.
• 16.10. Protective Industrial Products, Inc.

17. Strategic Recommendations

18. About Us & Disclaimer